Insulet reported $569M in Sales Revenues for its fiscal quarter ending in March of 2025.

Sales Change Date
Abbott USD 10.36B 610M Mar/2025
Align Technology USD 979.3M 15.92M Mar/2025
AtriCure USD 123.6M 677K Mar/2025
Avanos Medical USD 167.5M 12.1M Mar/2025
Baxter International USD 2.63B 123M Mar/2025
Becton, Dickinson and Co. USD 5.27B 102M Mar/2025
Boston Scientific USD 4.66B 99M Mar/2025
Cardinal Health USD 54.9B 364M Mar/2025
Cooper Companies USD 964.7M 53.7M Jan/2025
Dexcom USD 1.04B 73.5M Mar/2025
Edwards Lifesciences USD 1.41B 24.2M Mar/2025
Eli Lilly USD 12.73B 802.8M Mar/2025
Globus Medical USD 598.1M 59.19M Mar/2025
ICU Medical USD 599.49M 30.32M Mar/2025
Insulet USD 569M 28.5M Mar/2025
Integra LifeSciences USD 382.7M 59.95M Mar/2025
J&J USD 21.89B 630M Mar/2025
Masimo USD 372M 228.7M Mar/2025
Medtronic USD 8.29B 111M Jan/2025
Merit Medical Systems USD 355.4M 242K Mar/2025
Roche Holding CHF 31.64B 883M Dec/2024
Solventum Corp 2.1B 30M Mar/2025
Stryker USD 5.9B 536M Mar/2025
Tandem Diabetes Care USD 234.4M 48.25M Mar/2025
Teleflex USD 700.67M 94.74M Mar/2025
West Pharmaceutical Services USD 698M 50.8M Mar/2025
Zimmer Biomet Holdings USD 1.91B 113.2M Mar/2025